Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
- PMID: 33845777
- PMCID: PMC8040236
- DOI: 10.1186/s12879-021-06016-8
Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
Figures
Erratum for
-
Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.BMC Infect Dis. 2021 Feb 26;21(1):222. doi: 10.1186/s12879-021-05850-0. BMC Infect Dis. 2021. PMID: 33637050 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources